China, Nov. 6 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'study on the efficacy and safety of long-acting growth hormone in fast developing central precocious or early and fast puberty girls'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600136123
Registration Time: 2026/11/05
Type: Interventional study
Primary Sponsor: Zhongnan Hospital of Wuhan University
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=305722
Published by HT Digital Content Services with permission from Health Daily Digest....